1. Home
  2. TENX vs WBX Comparison

TENX vs WBX Comparison

Compare TENX & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$1.48

Market Cap

73.8M

Sector

Health Care

ML Signal

N/A

Logo Wallbox N.V.

WBX

Wallbox N.V.

N/A

Current Price

$2.04

Market Cap

63.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
TENX
WBX
Founded
1967
2015
Country
United States
Spain
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
73.8M
63.8M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
TENX
WBX
Price
$1.48
$2.04
Analyst Decision
Buy
Hold
Analyst Count
10
2
Target Price
★ $10.29
$4.00
AVG Volume (30 Days)
★ 1.4M
11.9K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$142.60
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.31
$1.93
52 Week High
$19.40
$6.18

Technical Indicators

Market Signals
Indicator
TENX
WBX
Relative Strength Index (RSI) 35.62 18.39
Support Level $1.34 N/A
Resistance Level $2.01 $2.87
Average True Range (ATR) 0.12 0.16
MACD 0.00 -0.07
Stochastic Oscillator 6.25 0.00

Price Performance

Historical Comparison
TENX
WBX

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

Share on Social Networks: